31 Stocks Moving In Monday's Mid-Day Session

Gainers

  • AveXis, Inc. AVXS surged 77.8 percent to $206.07 after the company agreed to be acquired by Novartis AG NVS for $8.7 billion.
  • Turtle Beach Corporation HEAR shares jumped 46.1 percent to $3.74 after the company raised its guidance for the first quarter.
  • Therapix Biosciences Ltd. TRPX gained 31.8 percent to $6.5625 after the company disclosed topline results of Phase IIa study at Yale University for Tourette Syndrome program.
  • REGENXBIO Inc. RGNX gained 28.7 percent to $35.0095 after dropping 3.89 percent on Friday.
  • uniQure N.V. QURE shares gained 18 percent to $25.92.
  • Nemaura Medical Inc. NMRD shares jumped 16.3 percent to $3.85. Nemaura Medical named Bashir Timol as Chief Business Officer.
  • Aileron Therapeutics, Inc. ALRN shares rose 15.2 percent to $7.335.
  • Century Aluminum Company CENX shares surged 13.7 percent to $19.09
  • Audentes Therapeutics, Inc. BOLD gained 13.2 percent to $31.805 after dropping 2.87 percent on Friday.
  • Abeona Therapeutics Inc. ABEO rose 12.4 percent to $15.74.
  • Natera, Inc. NTRA climbed 11.7 percent to $9.8301. Natera named Paul R. Billings, M.D., Ph.D., as Chief Medical Officer. Craig-Hallum initiated coverage on Natera, with a Buy rating.
  • Spark Therapeutics, Inc. ONCE climbed 11.6 percent to $69.23.
  • Sage Therapeutics, Inc. SAGE shares gained 10.4 percent to $156.02.
  • Leucadia National Corporation LUK climbed 10.3 percent to $24.005 after the company agreed to sell 48 percent of National Beef for $1.05 billion and its stake in Garcadia for $425 million. The company also announced a 25 million share buyback plan.
  • Verastem, Inc. VSTM shares climbed 7.9 percent to $3.195 after the company disclosed that the FDA has accepted New Drug Application for duvelisib.
  • bluebird bio, Inc. BLUE shares gained 7.1 percent to $174.275 after falling 4.38 percent on Thursday.
  • argenx SE ARGX climbed 6.4 percent to $79.64. argenx named Keith Woods as Chief Operating Officer. SunTrust initiated coverage on argenx with a Buy rating.
  • Cellect Biotechnology Ltd. APOP gained 5 percent to $6.81. The Israel-based developer of a novel stem cell enabling technology said it has completed a proof of concept testing of its new product prototype called ApoTrainer, which is designed to replace procedures like bone marrow transplants.
  • Merck & Co., Inc. MRK rose 3.4 percent to $55.17 after the company disclosed that its KEYTRUDA monotherapey met its primary endpoint in the Phase 3 KEYNOTE-042 study.


Check out these big penny stock gainers and losers

Losers

  • Menlo Therapeutics Inc. MNLO dipped 71.6 percent to $10.00 as the company disclosed that its Phase 2 trial of serlopitant for pruritus associated with atopic dermatitis did not meet primary and key secondary efficacy endpoints.
  • ACADIA Pharmaceuticals Inc. ACAD shares dropped 21.5 percent to $16.91.
  • NMI Holdings, Inc. NMIH shares fell 20.2 percent to $14.12.
  • Mechel PAO MTL shares dipped 18.4 percent to $3.47.
  • MGIC Investment Corporation MTG shares dropped 14.9 percent to $10.91. MGIC Investment is expected to release its Q1 financial results on Wednesday, April 18, 2018.
  • Essent Group Ltd. ESNT shares dipped 14.1 percent to $36.15.
  • Radian Group Inc. RDN declined 13.8 percent to $16.50.
  • Schmitt Industries, Inc. SMIT fell 11.1 percent to $2.41. Schmitt reported Q3 earnings of $0.00 per share, versus a year-ago loss of $0.04 per share. Its total sales rose 1.2 percent to $3.23 million.
  • Twin Disc, Incorporated TWIN shares fell 9.9 percent to $20.49.
  • Yandex N.V. YNDX shares fell 9.3 percent to $35.71 after declining 1.84 percent on Friday.
  • SSLJ.com Limited SSLJ declined 7.2 percent to $4.825 after dropping 2.80 percent on Friday.
  • Marrone Bio Innovations, Inc. MBII shares fell 6.1 percent to $3.0524 after jumping 21.72 percent on Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasFinancialsLosersMulti-Sector HoldingsTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!